EGFR and esophageal squamous cell carcinoma: Although several clinical studies show the beneficial effects of EGFR inhibitors in the treatment of ESCC [12, 13], evidence supporting the validity of EGFR-targeting therapies for esophageal cancer [14] is not robust.